PD—1/PD—L1抑制剂在非小细胞肺癌治疗中的应用进展(5)
[26]Wang C,Yu X,Wang W.A meta-analysis of efficacy and safety of antibodies targeting PD-1/PD-L1 in treatment of advanced nonsmall cell lung cancer[J].Medicine (Baltimore),2016,95(52):e5539.[27]Brahmer J,Reckamp KL,Baas P,et al.Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer[J].N Engl J Med ......
您现在查看是摘要页,全文长 2112 字符。